FlowSense Medical
Stage
Acq - P2P | AcquiredValuation
$0000About FlowSense Medical
FlowSense Medical aims to optimize renal care and fluid management. FlowSense's URINFO2000 enables real-time, continuous monitoring of urine output for the optimization of fluid management and acute renal care. The product provides clinicians with an early and on-going assessment of fluid balance and renal condition which can improve patient outcomes and reduce hospital costs.
Missing: FlowSense Medical's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: FlowSense Medical's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
FlowSense Medical Patents
FlowSense Medical has filed 10 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
5/1/2017 | 4/14/2020 | Fluid dynamics, Medical equipment, Catheters, Fluid mechanics, Medical treatments | Grant |
Application Date | 5/1/2017 |
|---|---|
Grant Date | 4/14/2020 |
Title | |
Related Topics | Fluid dynamics, Medical equipment, Catheters, Fluid mechanics, Medical treatments |
Status | Grant |
FlowSense Medical Frequently Asked Questions (FAQ)
What is FlowSense Medical's latest funding round?
FlowSense Medical's latest funding round is Acq - P2P.
Who are the investors of FlowSense Medical?
Investors of FlowSense Medical include Baxter International.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.